On the basis of sex: outcomes in myelodysplastic syndromes

Lancet Haematol. 2023 Feb;10(2):e83-e85. doi: 10.1016/S2352-3026(22)00352-0. Epub 2022 Nov 24.

Authors

Michael J Hochman¹, Amy E DeZern²

Affiliations

¹ Division of Hematologic Malignancies and Bone Marrow Transplantation, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
² Division of Hematologic Malignancies and Bone Marrow Transplantation, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA. Electronic address: adezern1@jhmi.edu.

PMID: 36436543
DOI: 10.1016/S2352-3026(22)00352-0

No abstract available

Publication types

Comment

MeSH terms

Humans
Myelodysplastic Syndromes* / therapy
Sex Factors*